POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON 24 MAY 2024

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.Medlive Technology Co. Ltd.医脉通科技有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 2192) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 MAY 2024 At the annual general meeting (the “AGM”) of Medlive Technology Co. Ltd. (the “Company”) held on Friday 24 May 2024 at 12:00 noon at E1 Red Manor International Bonded Innovation Park No. 1 Baijialou Chaoyang North Road Chaoyang District BeijingPRC all the proposed resolutions as set out in the notice of the AGM (the “Notice ofAGM”) dated 26 April 2024 were taken by way of poll. Unless otherwise stated capitalized terms used herein shall have the same meanings as those defined in the circular of the Company dated 26 April 2024.POLL RESULTS OF THE ANNUAL GENERAL MEETING As at the date of the AGM the issued share capital of the Company comprises 726962500 Shares which was the total number of Shares entitling the holders to attend and vote at the AGM. There were no restrictions on any Shareholders casting votes on any of the resolutions proposed at the AGM. There were no Shares entitling the holders to attend and abstain from voting in favour of the resolutions at the AGM as set out in Rule 13.40 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.Tricor Investor Services Limited the Company’s share registrar in Hong Kong acted as scrutineer for the vote-taking at the AGM. The poll results in respect of the respective resolutions proposed at the AGM were as follows: Number of Votes (%) Ordinary Resolutions For Against 1. To receive and consider the audited financial 664829040 0 statements and the Reports of the Directors and (100%) (0%) Auditors of the Company and its subsidiaries for the year ended 31 December 2023.– 1 –Number of Votes (%) Ordinary Resolutions For Against 2. To declare a final dividend for the year ended 31 663984040 652500 December 2023. (99.90%) (0.10%) 3. (i) To re-elect Ms. Tian Liping as a Director. 639649770 24986770 (96.24%)(3.76%) (ii) To re-elect Ms. Zhou Xin as a Director. 642491645 22144895 (96.67%)(3.33%) (iii) To re-elect Dr. Ma Jun as a Director. 600691838 63944702 (90.38%)(9.62%) (iv) T o a u t h o r i z e t h e B o a r d t o f i x t h e 642732243 21904297 remuneration of Directors. (96.70%) (3.30%) 4. To re-appoint Messrs. Ernst & Young as auditors 664636540 0 of the Company and to authorize the Directors to (100%) (0%) fix their remuneration. 5. To give a general mandate to the Directors to 664636540 0 repurchase shares in the Company not exceeding (100%) (0%) 10% of the aggregate nominal amount of the existing issued share capital#. 6. To give a general mandate to the Directors to 608773620 55862920 issue allot and deal with additional shares in the (91.59%) (8.41%) Company not exceeding 20% of the aggregate nominal amount of the existing issued share capital#. 7. To extend the general mandate granted to the 550066318 114570222 Directors to issue allot and deal with shares by (82.76%) (17.24%) the number of shares repurchased#.# The full text of the resolution is set out in the Notice of AGM.– 2 –As more than 50% of votes were cast in favor of resolutions numbered 1 to 7 the aforesaid ordinary resolutions proposed at the AGM were duly passed by the Shareholders by way of poll.ATTENDANCE OF DIRECTORS AT AGM All the Directors have attended the AGM either in person or by video conference.By Order of the Board Medlive Technology Co. Ltd.Tian Liping Chairwoman and Chief Executive Officer Hong Kong 24 May 2024 As at the date of this announcement the Board comprises Ms. Tian Liping Mr. Tian Lixin Mr. Tian Lijun and Ms. Zhou Xin as executive Directors; Mr. Eiji Tsuchiya and Mr. Kazutaka Kanairo as non-executive Directors; and Mr. Richard Yeh Dr. Ma Jun and Ms. Wang Shan as independent non-executive Directors.–3–